{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:10:55Z","timestamp":1787735455518,"version":"build-2784847793"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,6]]},"DOI":"10.7759\/cureus.48364","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T14:42:35Z","timestamp":1699281755000},"source":"Crossref","is-referenced-by-count":1,"title":["Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) Following Adenovirus Meningitis After First Delivery: Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Takashi","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rieko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Serizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0112-x","article-title":"Myelin oligodendrocyte glycoprotein antibodies in neurological disease","volume":"15","author":"Reindl M","year":"2019","unstructured":"Reindl M, Waters P. Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat Rev Neurol. 2019, 15:89-102. 10.1038\/s41582-018-0112-x","journal-title":"Nat Rev Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0256-1","article-title":"Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype","volume":"12","author":"Pr\u00f6bstel AK","year":"2015","unstructured":"Pr\u00f6bstel AK, Rudolf G, Dornmair K, et al.. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype. J Neuroinflammation. 2015, 12:46. 10.1186\/s12974-015-0256-1","journal-title":"J Neuroinflammation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/13524585221134214","article-title":"Pregnancy and post-partum in patients with myelin-oligodendrocyte glycoprotein antibody-associated disease","volume":"29","author":"Carra-Dalli\u00e8re C","year":"2023","unstructured":"Carra-Dalli\u00e8re C, Rollot F, Deschamps R, et al.. Pregnancy and post-partum in patients with myelin-oligodendrocyte glycoprotein antibody-associated disease. Mult Scler. 2023, 29:270-6. 10.1177\/13524585221134214","journal-title":"Mult Scler"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011744","article-title":"Pregnancy in patients with AQP4-ab, MOG-ab, or double-negative neuromyelitis optica disorder","volume":"96","author":"Collongues N","year":"2021","unstructured":"Collongues N, Alves Do Rego C, Bourre B, et al.. Pregnancy in patients with AQP4-ab, MOG-ab, or double-negative neuromyelitis optica disorder. Neurology. 2021, 96:e2006-15. 10.1212\/WNL.0000000000011744","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria","volume":"22","author":"Banwell B","year":"2023","unstructured":"Banwell B, Bennett JL, Marignier R, et al.. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol. 2023, 22:268-82. 10.1016\/S1474-4422(22)00431-8","journal-title":"Lancet Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7499\/j.issn.1008-8830.1910052","article-title":"Clinical features of children with myelin oligodendrocyte glycoprotein antibody-associated disorders [Article in Chinese]","volume":"22","author":"Zheng P","year":"2020","unstructured":"Zheng P, Zhang JZ, Sun J, et al.. Clinical features of children with myelin oligodendrocyte glycoprotein antibody-associated disorders [Article in Chinese]. Zhongguo Dang Dai Er Ke Za Zhi. 2020, 22:368-73. 10.7499\/j.issn.1008-8830.1910052","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/5528198","article-title":"An adult case of adenovirus-associated acute disseminated encephalomyelitis","volume":"2023","author":"Campbell D","year":"2023","unstructured":"Campbell D, Wong GS, Park H, McLeod G. An adult case of adenovirus-associated acute disseminated encephalomyelitis. Case Rep Infect Dis. 2023, 2023:10.1155\/2023\/5528198","journal-title":"Case Rep Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2021.e01213","article-title":"A rare fatal case of adenovirus serotype 4 associated acute disseminated encephalomyelitis in an adult: A case report","volume":"25","author":"Qamar Z","year":"2021","unstructured":"Qamar Z, Tucker CM, Kenyon LC, Royer TL. A rare fatal case of adenovirus serotype 4 associated acute disseminated encephalomyelitis in an adult: A case report. IDCases. 2021, 25:e01213. 10.1016\/j.idcr.2021.e01213","journal-title":"IDCases"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.845755","article-title":"MOG antibody-associated disorders following SARS-CoV-2 vaccination: a case report and literature review","volume":"13","author":"Matsumoto Y","year":"2022","unstructured":"Matsumoto Y, Ohyama A, Kubota T, et al.. MOG antibody-associated disorders following SARS-CoV-2 vaccination: a case report and literature review. Front Neurol. 2022, 13:10.3389\/fneur.2022.845755","journal-title":"Front Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.338642","article-title":"Tumefactive demyelinating brain lesion developing after administration of adenovector-based COVID-19 vaccine: a case report","volume":"70","author":"Garg RK","year":"2022","unstructured":"Garg RK, Malhotra HS, Kumar N, Pandey S, Patil MR, Uniyal R, Rizvi I. Tumefactive demyelinating brain lesion developing after administration of adenovector-based COVID-19 vaccine: a case report. Neurol India. 2022, 70:409-11. 10.4103\/0028-3886.338642","journal-title":"Neurol India"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200063","article-title":"Acute inflammatory diseases of the central nervous system after SARS-CoV-2 vaccination","volume":"10","author":"Francis AG","year":"2023","unstructured":"Francis AG, Elhadd K, Camera V, et al.. Acute inflammatory diseases of the central nervous system after SARS-CoV-2 vaccination. Neurol Neuroimmunol Neuroinflamm. 2023, 10:10.1212\/NXI.0000000000200063","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11194-9","article-title":"MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature","volume":"269","author":"Jarius S","year":"2022","unstructured":"Jarius S, Bieber N, Haas J, Wildemann B. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature. J Neurol. 2022, 269:5198-212. 10.1007\/s00415-022-11194-9","journal-title":"J Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher A","year":"2021","unstructured":"Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021, 384:2092-101. 10.1056\/NEJMoa2104840","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01556-7","article-title":"Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection","volume":"27","author":"Patone M","year":"2021","unstructured":"Patone M, Handunnetthi L, Saatci D, et al.. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med. 2021, 27:2144-53. 10.1038\/s41591-021-01556-7","journal-title":"Nat Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1349","article-title":"Autoimmunity elicited by the chemokine response to adenovirus vector vaccines may underlie vaccine-induced immune thrombotic thrombocytopaenia: a hypothesis","volume":"10","author":"McLean-Tooke A","year":"2021","unstructured":"McLean-Tooke A, Lucas M, French M. Autoimmunity elicited by the chemokine response to adenovirus vector vaccines may underlie vaccine-induced immune thrombotic thrombocytopaenia: a hypothesis. Clin Transl Immunology. 2021, 10:e1349. 10.1002\/cti2.1349","journal-title":"Clin Transl Immunology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.104175","article-title":"Clinical onset of CNS demyelinating disease after COVID-19 vaccination: denovo disease?","volume":"67","author":"Gernert JA","year":"2022","unstructured":"Gernert JA, Zimmermann H, Oswald E, Christmann T, K\u00fcmpfel T, Havla J. Clinical onset of CNS demyelinating disease after COVID-19 vaccination: denovo disease?. Mult Scler Relat Disord. 2022, 67:104175. 10.1016\/j.msard.2022.104175","journal-title":"Mult Scler Relat Disord"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000572","article-title":"Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?","volume":"6","author":"Stiebel-Kalish H","year":"2019","unstructured":"Stiebel-Kalish H, Hellmann MA, Mimouni M, Paul F, Bialer O, Bach M, Lotan I. Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?. Neurol Neuroimmunol Neuroinflamm. 2019, 6:e572. 10.1212\/NXI.0000000000000572","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-316880","article-title":"Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination","volume":"89","author":"Ramanathan S","year":"2018","unstructured":"Ramanathan S, Mohammad S, Tantsis E, et al.. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. J Neurol Neurosurg Psychiatry. 2018, 89:127-37. 10.1136\/jnnp-2017-316880","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/200281-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease-mogad-following-adenovirus-meningitis-after-first-delivery-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:08:47Z","timestamp":1707509327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/200281-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease-mogad-following-adenovirus-meningitis-after-first-delivery-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,6]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.48364","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,6]]}}}